Sabine Kopp, PhD World Health Organization

Sabine Kopp is Lead of World Health Organization’s (WHO) Norms and Standards for Pharmaceuticals Team. Among the various positions she held in WHO were Secretary for the International Nonproprietary Names (INN) Programme, Acting Team Coordinator for Quality Assurance and Safety of Medicines, Lead of the Medicines Quality Assurance Group, Programme Manager for the Quality Assurance and the Anticounterfeiting programmes and Acting Secretary of the International Medical Products Anti-Counterfeiting Taskforce (IMPACT). She was also actively involved in the WHO Member State mechanism on Substandard/spurious/falsely-labelled/falsified/counterfeit medical products.

Sabine is Secretary of the WHO Expert Committee on Specifications for Pharmaceutical Preparations and responsible for the coordination of WHO's activities related to the development and maintenance of international guidelines, GXPs, standards related to Medicines Quality Assurance and the International Pharmacopoeia, i.e. the normative work related to Medicines Quality Assurance within WHO, spanning from development and manufacturing to distribution and supply of medicines, and regulatory guidance such as stability requirements and interchangeability of multisource medicines. She also oversees WHO’s External Quality Assurance Assessment Scheme for quality control laboratories, serves as Secretary for the international meetings of world pharmacopoeias and is involved in activities aimed at enabling synergies and convergence globally.